| Year |
Citation |
Score |
| 2024 |
Kimura S, Sunouchi T, Watanabe S, Hoshino Y, Hidaka N, Kato H, Takeda S, Nangaku M, Makita N, Azuma K, Kojima T, Matsubara T, Saito T, Ito N. Latent metabolic bone disease, skeletal dysplasia and other conditions related to low bone formation among 38 patients with subtrochanteric femoral fractures: a retrospective observational study. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. PMID 38951164 DOI: 10.1007/s00198-024-07168-4 |
0.479 |
|
| 2023 |
Arai M, Ochi H, Sunamura S, Ito N, Nangaku M, Takeda S, Sato S. A Novel Long Noncoding RNA in Osteocytes Regulates Bone Formation through the Wnt/β-Catenin Signaling Pathway. International Journal of Molecular Sciences. 24. PMID 37686441 DOI: 10.3390/ijms241713633 |
0.368 |
|
| 2023 |
Utagawa K, Shin T, Yamada H, Ochi H, Sunamura S, Unno A, Akazawa C, Ema M, Takeda S, Okawa A, Sato S. Three-dimensional visualization of neural networks inside bone by Osteo-DISCO protocol and alteration of bone remodeling by surgical nerve ablation. Scientific Reports. 13: 4674. PMID 36949102 DOI: 10.1038/s41598-023-30492-4 |
0.59 |
|
| 2022 |
Omatsu Y, Aiba S, Maeta T, Higaki K, Aoki K, Watanabe H, Kondoh G, Nishimura R, Takeda S, Chung UI, Nagasawa T. Runx1 and Runx2 inhibit fibrotic conversion of cellular niches for hematopoietic stem cells. Nature Communications. 13: 2654. PMID 35551452 DOI: 10.1038/s41467-022-30266-y |
0.424 |
|
| 2021 |
Watanabe-Takano H, Ochi H, Chiba A, Matsuo A, Kanai Y, Fukuhara S, Ito N, Sako K, Miyazaki T, Tainaka K, Harada I, Sato S, Sawada Y, Minamino N, Takeda S, et al. Mechanical load regulates bone growth via periosteal Osteocrin. Cell Reports. 36: 109380. PMID 34260913 DOI: 10.1016/j.celrep.2021.109380 |
0.598 |
|
| 2020 |
Sato T, Iwata T, Usui M, Kokabu S, Sugamori Y, Takaku Y, Kobayashi T, Ito K, Matsumoto M, Takeda S, Xu R, Chida D. Bone phenotype in melanocortin 2 receptor-deficient mice. Bone Reports. 13: 100713. PMID 32964075 DOI: 10.1016/j.bonr.2020.100713 |
0.7 |
|
| 2019 |
Hashimoto K, Sato S, Ochi H, Takeda S, Futakuchi M. Calvarial Bone Implantation and Imaging of Tumor Cells in Mice. Bio-Protocol. 9: e3151. PMID 33654960 DOI: 10.21769/BioProtoc.3151 |
0.52 |
|
| 2019 |
Supakul S, Yao K, Ochi H, Shimada T, Hashimoto K, Sunamura S, Mabuchi Y, Tanaka M, Akazawa C, Nakamura T, Okawa A, Takeda S, Sato S. Pericytes as a Source of Osteogenic Cells in Bone Fracture Healing. International Journal of Molecular Sciences. 20. PMID 30832329 DOI: 10.3390/ijms20051079 |
0.49 |
|
| 2018 |
Fukuda M, Yoshizawa T, Karim MF, Sobuz SU, Korogi W, Kobayasi D, Okanishi H, Tasaki M, Ono K, Sawa T, Sato Y, Chirifu M, Masuda T, Nakamura T, Tanoue H, ... ... Takeda S, et al. SIRT7 has a critical role in bone formation by regulating lysine acylation of SP7/Osterix. Nature Communications. 9: 2833. PMID 30026585 DOI: 10.1038/s41467-018-05187-4 |
0.595 |
|
| 2018 |
Takeda S. [Body weight and bone/calcium metabolism. Relationship between insulin/glucose metabolism and bone/calcium metabolism.] Clinical Calcium. 28: 927-932. PMID 29950545 |
0.514 |
|
| 2018 |
Hashimoto K, Ochi H, Sunamura S, Kosaka N, Mabuchi Y, Fukuda T, Yao K, Kanda H, Ae K, Okawa A, Akazawa C, Ochiya T, Futakuchi M, Takeda S, Sato S. Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A. Proceedings of the National Academy of Sciences of the United States of America. PMID 29440427 DOI: 10.1073/pnas.1717363115 |
0.362 |
|
| 2017 |
Tanoue H, Morinaga J, Yoshizawa T, Yugami M, Itoh H, Nakamura T, Uehara Y, Masuda T, Odagiri H, Sugizaki T, Kadomatsu T, Miyata K, Endo M, Terada K, Ochi H, ... Takeda S, et al. Angiopoietin-like protein 2 promotes chondrogenic differentiation during bone growth as a cartilage matrix factor. Osteoarthritis and Cartilage. PMID 29074299 DOI: 10.1016/j.joca.2017.10.011 |
0.405 |
|
| 2017 |
Hirakawa H, Gatanaga H, Ochi H, Fukuda T, Sunamura S, Oka S, Takeda S, Sato S. Antiretroviral therapy containing HIV protease inhibitors enhances fracture risk by impairing osteoblast differentiation and bone quality. The Journal of Infectious Diseases. PMID 28525596 DOI: 10.1093/infdis/jix246 |
0.491 |
|
| 2016 |
Takarada T, Xu C, Ochi H, Nakazato R, Yamada D, Nakamura S, Kodama A, Shimba S, Mieda M, Fukasawa K, Ozaki K, Iezaki T, Fujikawa K, Yoneda Y, Numano R, ... ... Takeda S, et al. Bone Resorption Is Regulated by Circadian Clock in Osteoblasts. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 27925286 DOI: 10.1002/Jbmr.3053 |
0.795 |
|
| 2016 |
Iezaki T, Ozaki K, Fukasawa K, Inoue M, Kitajima S, Muneta T, Takeda S, Fujita H, Onishi Y, Horie T, Yoneda Y, Takarada T, Hinoi E. ATF3 deficiency in chondrocytes alleviates osteoarthritis development. The Journal of Pathology. PMID 27159257 DOI: 10.1002/Path.4739 |
0.533 |
|
| 2016 |
Sato S, Takeda S. [The regulation of various organs by osteoblasts]. Clinical Calcium. 26: 721-7. PMID 27117618 |
0.381 |
|
| 2016 |
Niimura M, Sato T, Enoki Y, Okubo M, Kokabu S, Takeda S, Yoda T. Semaphorin 3A Promotes Dendrite Elongation of Osteocytes in Association with Down-regulation of CDK6. In Vivo (Athens, Greece). 30: 231-236. PMID 27107080 |
0.475 |
|
| 2016 |
Xu C, Ochi H, Fukuda T, Sato S, Sunamura S, Takarada T, Hinoi E, Okawa A, Takeda S. Circadian Clock Regulates Bone Resorption in Mice. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 26841172 DOI: 10.1002/Jbmr.2803 |
0.767 |
|
| 2015 |
Sato T, Enoki Y, Sakamoto Y, Yokota K, Okubo M, Matsumoto M, Hayashi N, Usui M, Kokabu S, Mimura T, Nakazato Y, Araki N, Fukuda T, Okazaki Y, Suda T, ... Takeda S, et al. Donepezil prevents RANK-induced bone loss via inhibition of osteoclast differentiation by downregulating acetylcholinesterase. Heliyon. 1: e00013. PMID 27441211 DOI: 10.1016/j.heliyon.2015.e00013 |
0.459 |
|
| 2015 |
Takeda S. [Frontier in bone biology]. Nihon Rinsho. Japanese Journal of Clinical Medicine. 73: 1628-33. PMID 26529922 |
0.657 |
|
| 2015 |
Takeda S. [On "2015 Guidelines for Prevention and Treatment of Osteoporosis". Organ-network failure as a cause for osteoporosis]. Clinical Calcium. 25: 1307-12. PMID 26320530 |
0.579 |
|
| 2015 |
Fukuda T, Takeda S. [Frontiers in Live Bone Imaging Researches. Functional cross talk between bone and nervous system]. Clinical Calcium. 25: 891-8. PMID 26017867 |
0.682 |
|
| 2015 |
Ma C, Fukuda T, Ochi H, Sunamura S, Xu C, Xu R, Okawa A, Takeda S. Genetic determination of the cellular basis of the ghrelin-dependent bone remodeling. Molecular Metabolism. 4: 175-85. PMID 25737953 DOI: 10.1016/j.molmet.2015.01.002 |
0.701 |
|
| 2015 |
Bauer O, Sharir A, Kimura A, Hantisteanu S, Takeda S, Groner Y. Loss of osteoblast Runx3 produces severe congenital osteopenia Molecular and Cellular Biology. 35: 1097-1109. PMID 25605327 DOI: 10.1128/Mcb.01106-14 |
0.656 |
|
| 2015 |
Ochi H, Takeda S. [Bone and Calcium Research Update 2015. Metabolic crosstalk bone and other organs]. Clinical Calcium. 25: 11-20. PMID 25530518 |
0.672 |
|
| 2015 |
Suzuki W, Yamada A, Aizawa R, Suzuki D, Kassai H, Harada T, Nakayama M, Nagahama R, Maki K, Takeda S, Yamamoto M, Aiba A, Baba K, Kamijo R. Cdc42 is critical for cartilage development during endochondral ossification. Endocrinology. 156: 314-22. PMID 25343271 DOI: 10.1210/en.2014-1032 |
0.551 |
|
| 2015 |
Sato T, Enoki Y, Sakamoto Y, Yokota K, Okubo M, Matsumoto M, Hayashi N, Usui M, Kokabu S, Mimura T, Nakazato Y, Araki N, Fukuda T, Okazaki Y, Suda T, ... Takeda S, et al. Donepezil prevents RANK-induced bone loss via inhibition of osteoclast differentiation by downregulating acetylcholinesterase Heliyon. 1. DOI: 10.1016/j.heliyon.2015.e00013 |
0.579 |
|
| 2014 |
Takeda S. [Regulatory mechanism of bone metabolism] Nihon Jinzo Gakkai Shi. 56: 1188-1195. PMID 25551978 |
0.545 |
|
| 2014 |
Sato S, Takeda S. [Updates on Lifestyle-Related Diseases and Bone Metabolism. Bidirectional relationship between lifestyle-related diseases and bone metabolism]. Clinical Calcium. 24: 1591-8. PMID 25355142 |
0.452 |
|
| 2014 |
Sato S, Takeda S. [Regulation of bone metastasis by microRNAs] Clinical Calcium. 24: 1209-1215. PMID 25065873 |
0.483 |
|
| 2014 |
Ochi H, Takeda S. [Bone metabolism and cardiovascular function update. Nerve system and mutual interaction between bone and blood vessel]. Clinical Calcium. 24: 77-83. PMID 24976059 |
0.663 |
|
| 2014 |
Enoki Y, Sato T, Tanaka S, Iwata T, Usui M, Takeda S, Kokabu S, Matsumoto M, Okubo M, Nakashima K, Yamato M, Okano T, Fukuda T, Chida D, Imai Y, et al. Netrin-4 derived from murine vascular endothelial cells inhibits osteoclast differentiation in vitro and prevents bone loss in vivo. Febs Letters. 588: 2262-9. PMID 24846137 DOI: 10.1016/j.febslet.2014.05.009 |
0.599 |
|
| 2013 |
Fukuda T, Takeda S. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Regulation of bone homeostasis by nerve system]. Clinical Calcium. 23: 1279-83. PMID 23999363 |
0.571 |
|
| 2013 |
Fukuda T, Takeda S, Xu R, Ochi H, Sunamura S, Sato T, Shibata S, Yoshida Y, Gu Z, Kimura A, Ma C, Xu C, Bando W, Fujita K, Shinomiya K, et al. Sema3A regulates bone-mass accrual through sensory innervations. Nature. 497: 490-3. PMID 23644455 DOI: 10.1038/Nature12115 |
0.684 |
|
| 2013 |
Takarada T, Hinoi E, Nakazato R, Ochi H, Xu C, Tsuchikane A, Takeda S, Karsenty G, Abe T, Kiyonari H, Yoneda Y. An analysis of skeletal development in osteoblast-specific and chondrocyte-specific runt-related transcription factor-2 (Runx2) knockout mice. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 28: 2064-9. PMID 23553905 DOI: 10.1002/Jbmr.1945 |
0.692 |
|
| 2013 |
Takeda S. [Intercommunication between bone and central nervous system] Clinical Calcium. 23: 173-179. PMID 23354083 |
0.665 |
|
| 2013 |
Itoh S, Sekino Y, Shinomiya K, Takeda S. The effects of risedronate administered in combination with a proton pump inhibitor for the treatment of osteoporosis. Journal of Bone and Mineral Metabolism. 31: 206-11. PMID 23138352 DOI: 10.1007/s00774-012-0406-9 |
0.386 |
|
| 2013 |
Fukuda T, Takeda S, Xu R, Ochi H, Sunamura S, Sato T, Shibata S, Yoshida Y, Gu Z, Kimura A, Ma C, Xu C, Bando W, Fujita K, Shinomiya K, et al. Correction: Corrigendum: Sema3A regulates bone-mass accrual through sensory innervations Nature. 500: 612-612. DOI: 10.1038/Nature12418 |
0.613 |
|
| 2013 |
Takeda S. The Central Control of Bone Mass Translational Endocrinology of Bone. 27-38. DOI: 10.1016/B978-0-12-415784-2.00003-8 |
0.613 |
|
| 2012 |
Takeda S. [Diabetes mellitus and osteoporosis. Cross talk between bone and other internal organs on lifestyle-related disease] Clinical Calcium. 22: 1315-1322. PMID 22932285 |
0.599 |
|
| 2012 |
Iwasaki M, Piao J, Kimura A, Sato S, Inose H, Ochi H, Asou Y, Shinomiya K, Okawa A, Takeda S. Runx2 haploinsufficiency ameliorates the development of ossification of the posterior longitudinal ligament. Plos One. 7: e43372. PMID 22927960 DOI: 10.1371/journal.pone.0043372 |
0.345 |
|
| 2012 |
Hanyu R, Wehbi VL, Hayata T, Moriya S, Feinstein TN, Ezura Y, Nagao M, Saita Y, Hemmi H, Notomi T, Nakamoto T, Schipani E, Takeda S, Kaneko K, Kurosawa H, et al. Anabolic action of parathyroid hormone regulated by the β2-adrenergic receptor. Proceedings of the National Academy of Sciences of the United States of America. 109: 7433-8. PMID 22538810 DOI: 10.1073/Pnas.1109036109 |
0.728 |
|
| 2012 |
Fujita K, Iwasaki M, Ochi H, Fukuda T, Ma C, Miyamoto T, Takitani K, Negishi-Koga T, Sunamura S, Kodama T, Takayanagi H, Tamai H, Kato S, Arai H, Shinomiya K, ... ... Takeda S, et al. Vitamin E decreases bone mass by stimulating osteoclast fusion. Nature Medicine. 18: 589-94. PMID 22388090 DOI: 10.1038/nm.2659 |
0.626 |
|
| 2012 |
Hinoi E, Ochi H, Takarada T, Nakatani E, Iezaki T, Nakajima H, Fujita H, Takahata Y, Hidano S, Kobayashi T, Takeda S, Yoneda Y. Positive regulation of osteoclastic differentiation by growth differentiation factor 15 upregulated in osteocytic cells under hypoxia. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 27: 938-49. PMID 22190281 DOI: 10.1002/Jbmr.1538 |
0.79 |
|
| 2012 |
Fujita K, Iwasaki M, Ochi H, Fukuda T, Ma C, Miyamoto T, Takitani K, Negishi-Koga T, Sunamura S, Kodama T, Takayanagi H, Tamai H, Kato S, Arai H, Shinomiya K, ... ... Takeda S, et al. Erratum: Vitamin E decreases bone mass by stimulating osteoclast fusion Nature Medicine. 18: 1445-1445. DOI: 10.1038/NM0912-1445A |
0.482 |
|
| 2011 |
Nagao M, Feinstein TN, Ezura Y, Hayata T, Notomi T, Saita Y, Hanyu R, Hemmi H, Izu Y, Takeda S, Wang K, Rittling S, Nakamoto T, Kaneko K, Kurosawa H, et al. Sympathetic control of bone mass regulated by osteopontin. Proceedings of the National Academy of Sciences of the United States of America. 108: 17767-72. PMID 21990347 DOI: 10.1073/Pnas.1109402108 |
0.786 |
|
| 2011 |
Takeda S. [Novel regulatory mechanism of bone metabolism] Nihon Rinsho. Japanese Journal of Clinical Medicine. 69: 1209-1214. PMID 21774359 |
0.571 |
|
| 2011 |
Takeda S. [Osteoporosis] Nihon Rinsho. Japanese Journal of Clinical Medicine. 69: 426-431. PMID 21766636 |
0.487 |
|
| 2011 |
Takeda S. [Control of bone metabolism by central nervous system] Clinical Calcium. 21: 691-696. PMID 21532118 |
0.581 |
|
| 2011 |
Ogata N, Shinoda Y, Wettschureck N, Offermanns S, Takeda S, Nakamura K, Segre GV, Chung UI, Kawaguchi H. G alpha(q) signal in osteoblasts is inhibitory to the osteoanabolic action of parathyroid hormone. The Journal of Biological Chemistry. 286: 13733-40. PMID 21345793 DOI: 10.1074/jbc.M110.200196 |
0.399 |
|
| 2011 |
Ochi H, Takeda S. [Animal models for bone and joint disease. The genetically-modified mice as a tool for osteoporosis research] Clinical Calcium. 21: 226-232. PMID 21289419 |
0.335 |
|
| 2010 |
Takeda S. [Paradigm shift in regulation of bone metabolism--bone and nervous system] Clinical Calcium. 20: 1791. PMID 21313787 |
0.642 |
|
| 2010 |
Fukuda T, Takeda S. [Control of bone remodeling by nervous system. Regulation of bone metabolism by appetite regulating neuropeptides]. Clinical Calcium. 20: 1807-13. PMID 21123932 |
0.625 |
|
| 2010 |
Nishikawa K, Nakashima T, Takeda S, Isogai M, Hamada M, Kimura A, Kodama T, Yamaguchi A, Owen MJ, Takahashi S, Takayanagi H. Maf promotes osteoblast differentiation in mice by mediating the age-related switch in mesenchymal cell differentiation. The Journal of Clinical Investigation. 120: 3455-65. PMID 20877012 DOI: 10.1172/Jci42528 |
0.535 |
|
| 2010 |
Tanaka M, Suganami T, Sugita S, Shimoda Y, Kasahara M, Aoe S, Takeya M, Takeda S, Kamei Y, Ogawa Y. Role of central leptin signaling in renal macrophage infiltration. Endocrine Journal. 57: 61-72. PMID 19851035 DOI: JST.JSTAGE/endocrj/K09E-296 |
0.368 |
|
| 2010 |
Takeda S. Control of Bone Remodeling by the Central Nervous System. Nihon Naika Gakkai Zasshi. 99: 1928-1933. DOI: 10.2169/NAIKA.99.1928 |
0.626 |
|
| 2010 |
Takeda⁎ S. Regulation of bone remodelling by circadian genes Bone. 47: S20-S21. DOI: 10.1016/J.BONE.2010.04.020 |
0.576 |
|
| 2009 |
Takeda S. Hormones and osteoporosis update. Regulation of bone remodeling by adipokines Clinical Calcium. 19: 1009-1014. PMID 19567999 |
0.681 |
|
| 2009 |
Takeda S. Hormones and osteoporosis update. Regulation of bone remodeling by neuropeptides and neurotransmitters Clinical Calcium. 19: 990-996. PMID 19567996 |
0.679 |
|
| 2009 |
Kimura A, Takeda S. [Clinical aspect of recent progress in phosphate metabolism. Bone as an endocrine organ]. Clinical Calcium. 19: 821-5. PMID 19483277 |
0.546 |
|
| 2009 |
Takeda S. Osteoporosis: A neuroskeletal disease? International Journal of Biochemistry and Cell Biology. 41: 455-459. PMID 18761104 DOI: 10.1016/j.biocel.2008.08.002 |
0.646 |
|
| 2008 |
Nojiri Y, Takeda S, Enomoto M, Nishitsuji H, Masuda T, Sotome S, Shinomiya K. Co-overexpression of GDNF and GFRalpha1 induces neural differentiation in neural progenitor cells in comparison to bone marrow stromal cells. Journal of Medical and Dental Sciences. 55: 121-8. PMID 19845157 |
0.304 |
|
| 2008 |
Tominaga H, Maeda S, Hayashi M, Takeda S, Akira S, Komiya S, Nakamura T, Akiyama H, Imamura T. CCAAT/enhancer-binding protein beta promotes osteoblast differentiation by enhancing Runx2 activity with ATF4. Molecular Biology of the Cell. 19: 5373-86. PMID 18843047 DOI: 10.1091/Mbc.E08-03-0329 |
0.466 |
|
| 2008 |
Sato S, Kimura A, Ozdemir J, Asou Y, Miyazaki M, Jinno T, Ae K, Liu X, Osaki M, Takeuchi Y, Fukumoto S, Kawaguchi H, Haro H, Shinomiya K, Karsenty G, ... Takeda S, et al. The distinct role of the Runx proteins in chondrocyte differentiation and intervertebral disc degeneration: findings in murine models and in human disease. Arthritis and Rheumatism. 58: 2764-75. PMID 18759297 DOI: 10.1002/Art.23805 |
0.491 |
|
| 2008 |
Takeda S. Central control of bone remodelling Journal of Neuroendocrinology. 20: 802-807. PMID 18601702 DOI: 10.1111/j.1365-2826.2008.01732.x |
0.591 |
|
| 2008 |
Takeda S. Effect of obesity on bone metabolism Clinical Calcium. 18: 632-637. PMID 18445881 |
0.545 |
|
| 2008 |
Takeda S, Karsenty G. Molecular bases of the sympathetic regulation of bone mass. Bone. 42: 837-40. PMID 18295563 DOI: 10.1016/J.Bone.2008.01.005 |
0.713 |
|
| 2008 |
Takeda S. Genomic approaches to bone and joint diseases. Control of bone remodeling by hormones and neuronal pathways Clinical Calcium. 18: 216-221. PMID 18245892 |
0.655 |
|
| 2008 |
Takeda S, Ducy P. Regulation of Bone Remodeling by Central and Peripheral Nervous Signals Principles of Bone Biology, Two-Volume Set. 2: 1059-1068. DOI: 10.1016/B978-0-12-373884-4.00016-1 |
0.794 |
|
| 2007 |
Takeda S. Control of bone remodeling by leptin and sympathetic nervous system Nippon Rinsho. Japanese Journal of Clinical Medicine. 65: 105-109. PMID 18161091 |
0.641 |
|
| 2007 |
Sato S, Hanada R, Kimura A, Abe T, Matsumoto T, Iwasaki M, Inose H, Ida T, Mieda M, Takeuchi Y, Fukumoto S, Fujita T, Kato S, Kangawa K, Kojima M, ... ... Takeda S, et al. Central control of bone remodeling by neuromedin U Nature Medicine. 13: 1234-1240. PMID 17873881 DOI: 10.1038/nm1640 |
0.743 |
|
| 2007 |
Nakamura T, Imai Y, Matsumoto T, Sato S, Takeuchi K, Igarashi K, Harada Y, Azuma Y, Krust A, Yamamoto Y, Nishina H, Takeda S, Takayanagi H, Metzger D, Kanno J, et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell. 130: 811-23. PMID 17803905 DOI: 10.1016/J.Cell.2007.07.025 |
0.639 |
|
| 2006 |
Kamekura S, Kawasaki Y, Hoshi K, Shimoaka T, Chikuda H, Maruyama Z, Komori T, Sato S, Takeda S, Karsenty G, Nakamura K, Chung UI, Kawaguchi H. Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. Arthritis and Rheumatism. 54: 2462-70. PMID 16868966 DOI: 10.1002/Art.22041 |
0.424 |
|
| 2005 |
Kondo H, Nifuji A, Takeda S, Ezura Y, Rittling SR, Denhardt DT, Nakashima K, Karsenty G, Noda M. Unloading induces osteoblastic cell suppression and osteoclastic cell activation to lead to bone loss via sympathetic nervous system. The Journal of Biological Chemistry. 280: 30192-200. PMID 15961387 DOI: 10.1074/Jbc.M504179200 |
0.768 |
|
| 2005 |
Takeda S. Central control of bone metabolism Clinical Calcium. 15: 797-804. PMID 15876742 |
0.719 |
|
| 2005 |
Fukushima N, Hanada R, Teranishi H, Fukue Y, Tachibana T, Ishikawa H, Takeda S, Takeuchi Y, Fukumoto S, Kangawa K, Nagata K, Kojima M. Ghrelin directly regulates bone formation. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 20: 790-8. PMID 15824852 DOI: 10.1359/JBMR.041237 |
0.626 |
|
| 2005 |
Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, Kondo H, Richards WG, Bannon TW, Noda M, Clement K, Vaisse C, Karsenty G. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature. 434: 514-20. PMID 15724149 DOI: 10.1038/Nature03398 |
0.83 |
|
| 2005 |
Takeda S. Central control of bone remodeling Biochemical and Biophysical Research Communications. 328: 697-699. PMID 15694403 DOI: 10.1016/j.bbrc.2004.11.071 |
0.687 |
|
| 2004 |
Takeuchi Y, Takeda S. [Statins as possible therapeutic tools for osteoporosis]. Clinical Calcium. 14: 302-7. PMID 15576989 |
0.433 |
|
| 2004 |
Takeda S. Leptin and beta-blockers in bone metabolism Clinical Calcium. 14: 241-247. PMID 15576979 |
0.567 |
|
| 2004 |
Takeda S, Takeuchi Y. [Statins]. Clinical Calcium. 14: 180-4. PMID 15576975 |
0.541 |
|
| 2004 |
Elefteriou F, Takeda S, Ebihara K, Magre J, Patano N, Kim CA, Ogawa Y, Liu X, Ware SM, Craigen WJ, Robert JJ, Vinson C, Nakao K, Capeau J, Karsenty G. Serum leptin level is a regulator of bone mass. Proceedings of the National Academy of Sciences of the United States of America. 101: 3258-63. PMID 14978271 DOI: 10.1073/Pnas.0308744101 |
0.829 |
|
| 2003 |
Elefteriou F, Takeda S, Liu X, Armstrong D, Karsenty G. Monosodium glutamate-sensitive hypothalamic neurons contribute to the control of bone mass. Endocrinology. 144: 3842-7. PMID 12933656 DOI: 10.1210/En.2003-0369 |
0.831 |
|
| 2003 |
Terpstra L, Prud'homme J, Arabian A, Takeda S, Karsenty G, Dedhar S, St-Arnaud R. Reduced chondrocyte proliferation and chondrodysplasia in mice lacking the integrin-linked kinase in chondrocytes. The Journal of Cell Biology. 162: 139-48. PMID 12835312 DOI: 10.1083/Jcb.200302066 |
0.581 |
|
| 2003 |
Takeda S, Elefteriou F, Karsenty G. Common endocrine control of body weight, reproduction, and bone mass. Annual Review of Nutrition. 23: 403-11. PMID 12730321 DOI: 10.1146/Annurev.Nutr.23.011702.073312 |
0.831 |
|
| 2002 |
Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G. Leptin regulates bone formation via the sympathetic nervous system. Cell. 111: 305-17. PMID 12419242 DOI: 10.1016/S0092-8674(02)01049-8 |
0.822 |
|
| 2002 |
Takeuchi Y, Watanabe S, Ishii G, Takeda S, Nakayama K, Fukumoto S, Kaneta Y, Inoue D, Matsumoto T, Harigaya K, Fujita T. Interleukin-11 as a stimulatory factor for bone formation prevents bone loss with advancing age in mice. The Journal of Biological Chemistry. 277: 49011-8. PMID 12384500 DOI: 10.1074/jbc.M207804200 |
0.623 |
|
| 2001 |
Takeda S, Karsenty G. Central control of bone formation. Journal of Bone and Mineral Metabolism. 19: 195-8. PMID 11368306 DOI: 10.1007/S007740170042 |
0.802 |
|
| 2001 |
Takeda S, Bonnamy JP, Owen MJ, Ducy P, Karsenty G. Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. Genes & Development. 15: 467-81. PMID 11230154 DOI: 10.1101/Gad.845101 |
0.736 |
|
| 2001 |
Amling M, Takeda S, Karsenty G. A neuro (endo)crine regulation of bone remodeling. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 22: 970-5. PMID 11056473 DOI: 10.1002/1521-1878(200011)22:11<970::Aid-Bies3>3.0.Co;2-L |
0.816 |
|
| 2000 |
Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell. 100: 197-207. PMID 10660043 DOI: 10.1016/S0092-8674(00)81558-5 |
0.831 |
|
| 1999 |
Takeda S, Yoshizawa T, Nagai Y, Yamato H, Fukumoto S, Sekine K, Kato S, Matsumoto T, Fujita T. Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: studies using VDR knockout mice. Endocrinology. 140: 1005-8. PMID 9927335 DOI: 10.1210/endo.140.2.6673 |
0.404 |
|
| 1997 |
Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y, Kawakami T, Arioka K, Sato H, Uchiyama Y, Masushige S, Fukamizu A, Matsumoto T, Kato S. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nature Genetics. 16: 391-6. PMID 9241280 DOI: 10.1038/ng0897-391 |
0.447 |
|
| 1996 |
Nakayama K, Fukumoto S, Takeda S, Takeuchi Y, Ishikawa T, Miura M, Hata K, Hane M, Tamura Y, Tanaka Y, Kitaoka M, Obara T, Ogata E, Matsumoto T. Differences in bone and vitamin D metabolism between primary hyperparathyroidism and malignancy-associated hypercalcemia. The Journal of Clinical Endocrinology and Metabolism. 81: 607-11. PMID 8636276 DOI: 10.1210/JCEM.81.2.8636276 |
0.48 |
|
| 1985 |
SATO T, KIMURA H, TAKEDA S, KIMURA N, SUZUKI M. Pathophysiological study of hemorrhagic bone cyst - The changes of components of the cyst fluid according to its inflammatory condition. Japanese Journal of Oral & Maxillofacial Surgery. 31: 2257-2260. DOI: 10.5794/JJOMS.31.2257 |
0.418 |
|
| Show low-probability matches. |